新功能、新界面、新体验,扫描即可下载生物谷APP!
首页 » 投资 » 丙肝“天价”新药事件引发生物科技板泡沫破灭“恐慌”

丙肝“天价”新药事件引发生物科技板泡沫破灭“恐慌”

来源:生物谷 2014-03-27 09:01

2014年3月25日讯 /生物谷BIOON/--2013年12月8日,FDA批准治疗丙肝的药物Sovaldi上市,该药由美国吉利德科学公司(Gilead Sciences Inc)生产,治愈率高达90%。然而Sovaldi每瓶28片,一日一片,售价2.8万美元,即每片1000美元。大多数患者需服用3瓶完成一个疗程,费用达8.4万美元。随后立法者致信该公司,要求其限时回复“天价药”的根据。

该事件引发过去几天内生物科技板股票交易量大增,板块指数两天降幅达到近两年内最高。据bioworld 杂志数据显示,生物技术蓝筹股周一收盘价两天内下跌7.5%。

然而对此事件的敏感并未引发全面恐慌,投资者对生物技术公司前景依然持积极态度。本周二数据显示生物技术板块开始恢复,周二收盘价显示生物技术蓝筹股指数与昨日持平,证明生技股票抛售业已停止。

本周二其他板块股票也表现良好,道琼斯工业指数收盘价上涨0.6%, 消费者对生物技术板的信心高于预期,有望再次推翻生技板所谓的“泡沫理论”。(生物谷Bioon.com)

 

 详细英文报道:

Biotech’s bubble burst? No, fundamentals remain sound

It is alliteratively satisfying to combine “biotech” with “bubble,” and the two words have been bandied around frequently for the past couple of days causing massive trading in biotech shares that has resulted in the largest two-day declines that biotech indices have experienced since early 2012. The selloff trigger was attributed to concerns in U.S. government circles over the price of a hepatitis C drug treatment from Gilead Sciences Inc.

While this negative sentiment did not cause a full-scale panic among investors, it certainly got ugly for the sector with the BioWorld Blue Chip Biotech Index closing Monday down 7.5 percent for the two-day trading period, with all companies in the group seeing their share values fall. For example, biotech’s top two companies by market cap, Foster City, Calif.-based Gilead and Thousand Oaks, Calif.-based Amgen Inc., recorded a drop in share value of 4.7 percent and 4.5 percent, respectively.

Commenting on the state of affairs, Wall Street analysts were quick to say that there wasn’t any reason to hit the panic button just yet. The overall sentiment among investors still remains positive with the expectation that biotech is staying on track to record another excellent year. With saner heads prevailing, the sector started to recover and by close of business Tuesday the Blue Chip Biotech Index finished the day unchanged, demonstrating that the selloff looked like it had run out of steam.

With the general markets also having a good day and the Dow Jones Industrial index closing up 0.6 percent, buoyed by better-than-expected consumer confidence data, biotech is poised once again to burst the bubbleology theories.


温馨提示:87%用户都在生物谷APP上阅读,扫描立刻下载! 天天精彩!


相关标签

最新会议 培训班 期刊库